Cervical cancer
Results
Phase 2
This trial looked at gemcitabine and docetaxel (Taxotere) for women whose cervical cancer had come back after treatment.
Recruitment start: 1 February 2005
Recruitment end: 12 February 2009
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Paul Symonds
Eli Lilly and Company Limited
Experimental Cancer Medicine Centre (ECMC)
Sanofi
Scottish Gynaecological Cancer Trials Group
NIHR Clinical Research Network: Cancer
Last reviewed: 17 October 2012
CRUK internal database number: 252